CN101633661A - 制备斑蝥酸钠的工艺 - Google Patents
制备斑蝥酸钠的工艺 Download PDFInfo
- Publication number
- CN101633661A CN101633661A CN 200910169374 CN200910169374A CN101633661A CN 101633661 A CN101633661 A CN 101633661A CN 200910169374 CN200910169374 CN 200910169374 CN 200910169374 A CN200910169374 A CN 200910169374A CN 101633661 A CN101633661 A CN 101633661A
- Authority
- CN
- China
- Prior art keywords
- cantharidin
- sodium
- cantharidinate
- add
- sodium cantharidinate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 title abstract description 52
- 229910052708 sodium Inorganic materials 0.000 title abstract description 52
- 239000011734 sodium Substances 0.000 title abstract description 52
- 238000004519 manufacturing process Methods 0.000 title abstract description 5
- DHZBEENLJMYSHQ-XCVPVQRUSA-N cantharidin Chemical compound C([C@@H]1O2)C[C@@H]2[C@]2(C)[C@@]1(C)C(=O)OC2=O DHZBEENLJMYSHQ-XCVPVQRUSA-N 0.000 claims abstract description 77
- 229940095758 cantharidin Drugs 0.000 claims abstract description 76
- 229930008397 cantharidin Natural products 0.000 claims abstract description 76
- DHZBEENLJMYSHQ-UHFFFAOYSA-N cantharidine Natural products O1C2CCC1C1(C)C2(C)C(=O)OC1=O DHZBEENLJMYSHQ-UHFFFAOYSA-N 0.000 claims abstract description 76
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical class CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 34
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 22
- 238000000605 extraction Methods 0.000 claims description 22
- 239000000843 powder Substances 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 10
- 229920006395 saturated elastomer Polymers 0.000 claims description 10
- 238000002791 soaking Methods 0.000 claims description 2
- 241000623906 Lytta vesicatoria Species 0.000 claims 2
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 12
- 239000007788 liquid Substances 0.000 abstract description 8
- 238000007670 refining Methods 0.000 abstract description 5
- 238000002347 injection Methods 0.000 abstract description 3
- 239000007924 injection Substances 0.000 abstract description 3
- -1 large infusions Substances 0.000 abstract description 3
- 239000002674 ointment Substances 0.000 abstract description 3
- 239000002775 capsule Substances 0.000 abstract description 2
- 239000002552 dosage form Substances 0.000 abstract description 2
- 239000008187 granular material Substances 0.000 abstract description 2
- 238000001802 infusion Methods 0.000 abstract description 2
- 239000003826 tablet Substances 0.000 abstract description 2
- 230000002194 synthesizing effect Effects 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 31
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 30
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 20
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 20
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 20
- 239000000243 solution Substances 0.000 description 19
- 239000000047 product Substances 0.000 description 14
- 238000000746 purification Methods 0.000 description 14
- 239000002904 solvent Substances 0.000 description 11
- 239000003208 petroleum Substances 0.000 description 10
- 230000015572 biosynthetic process Effects 0.000 description 9
- 238000003786 synthesis reaction Methods 0.000 description 9
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- 239000012085 test solution Substances 0.000 description 6
- 238000012546 transfer Methods 0.000 description 6
- 241000124079 Mylabris Species 0.000 description 5
- 206010028980 Neoplasm Diseases 0.000 description 5
- 239000013078 crystal Substances 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 238000002386 leaching Methods 0.000 description 5
- 231100000331 toxic Toxicity 0.000 description 5
- 230000002588 toxic effect Effects 0.000 description 5
- 239000012141 concentrate Substances 0.000 description 4
- 239000012043 crude product Substances 0.000 description 4
- 239000004744 fabric Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 239000013558 reference substance Substances 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 239000002689 soil Substances 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- 241000238631 Hexapoda Species 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 238000005238 degreasing Methods 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 201000007270 liver cancer Diseases 0.000 description 3
- 229910001220 stainless steel Inorganic materials 0.000 description 3
- 239000010935 stainless steel Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 206010006187 Breast cancer Diseases 0.000 description 2
- 208000026310 Breast neoplasm Diseases 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 208000002474 Tinea Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 2
- 229940041181 antineoplastic drug Drugs 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000003405 delayed action preparation Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 238000005187 foaming Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 201000005202 lung cancer Diseases 0.000 description 2
- 208000020816 lung neoplasm Diseases 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 238000011003 system suitability test Methods 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 241000131283 Cantharis Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 208000002699 Digestive System Neoplasms Diseases 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- 201000009053 Neurodermatitis Diseases 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010064127 Solar lentigo Diseases 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 241000893966 Trichophyton verrucosum Species 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000002888 effect on disease Effects 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 201000004101 esophageal cancer Diseases 0.000 description 1
- 238000010812 external standard method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical group CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 description 1
- FPLYNRPOIZEADP-UHFFFAOYSA-N octylsilane Chemical group CCCCCCCC[SiH3] FPLYNRPOIZEADP-UHFFFAOYSA-N 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 231100000816 toxic dose Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009101693745A CN101633661B (zh) | 2007-02-13 | 2007-02-13 | 制备斑蝥酸钠的工艺 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009101693745A CN101633661B (zh) | 2007-02-13 | 2007-02-13 | 制备斑蝥酸钠的工艺 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2007100638506A Division CN100545164C (zh) | 2007-02-13 | 2007-02-13 | 斑蝥酸钠的制备工艺 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101633661A true CN101633661A (zh) | 2010-01-27 |
CN101633661B CN101633661B (zh) | 2011-06-01 |
Family
ID=41593015
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009101693745A Expired - Fee Related CN101633661B (zh) | 2007-02-13 | 2007-02-13 | 制备斑蝥酸钠的工艺 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101633661B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102268006A (zh) * | 2011-06-15 | 2011-12-07 | 北京联合大学生物化学工程学院 | 一种复合酶提取斑蝥素的方法 |
CN102276619A (zh) * | 2011-06-21 | 2011-12-14 | 贵州金桥药业有限公司 | 斑蝥酸钠的制备方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1586500A (zh) * | 2004-07-19 | 2005-03-02 | 俞锋 | 治疗肿瘤的斑蝥酸钠注射剂及其制备方法 |
-
2007
- 2007-02-13 CN CN2009101693745A patent/CN101633661B/zh not_active Expired - Fee Related
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102268006A (zh) * | 2011-06-15 | 2011-12-07 | 北京联合大学生物化学工程学院 | 一种复合酶提取斑蝥素的方法 |
CN102268006B (zh) * | 2011-06-15 | 2013-08-14 | 北京联合大学生物化学工程学院 | 一种复合酶提取斑蝥素的方法 |
CN102276619A (zh) * | 2011-06-21 | 2011-12-14 | 贵州金桥药业有限公司 | 斑蝥酸钠的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101633661B (zh) | 2011-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100545164C (zh) | 斑蝥酸钠的制备工艺 | |
CN107641128B (zh) | 一种高效提取河豚毒素的方法 | |
CN101693730B (zh) | 芒果叶苷及其制备方法与应用 | |
WO2017133465A1 (zh) | 一种黄芩苷镁化合物及其制备方法与它的用途 | |
CN100417643C (zh) | 一种从落叶松中提取二氢槲皮素的方法 | |
CN102127042B (zh) | 一类高异黄酮化合物及制备方法和用途 | |
JP2004518751A (ja) | Liangtoujian抽出物の製造方法、その抽出物を含有する医薬組成物及びその用途 | |
CN103494846A (zh) | 海南冬青总三萜提取物及其制备方法与用途 | |
CN101633661A (zh) | 制备斑蝥酸钠的工艺 | |
CN102552243A (zh) | 杨梅醇和/或杨梅酮在制备抗肿瘤药物中的应用 | |
CN102477041B (zh) | 一种盐酸千金藤素的制备方法 | |
CN102688248A (zh) | 蟾蜍甾烯类化合物在制备治疗口腔黏膜恶性肿瘤药物中的应用 | |
CN101411779B (zh) | 一种治疗肝癌的中药有效部位组合物及其制备方法 | |
CN104558222A (zh) | 具有抗肿瘤活性的厚壳贻贝多糖类化合物的制备工艺 | |
CN100478003C (zh) | 一种冬凌草提取方法 | |
CN110144015A (zh) | 一种灵芝多糖、灵芝三萜酸及氨基酸的同步提取纯化方法 | |
CN101648948B (zh) | 降血压药物3-烷氧基-芒果苷、合成及应用 | |
JPH06502190A (ja) | ジアセチルレインの製造方法 | |
CN112979640B (zh) | 一类生物碱二聚体类化合物及其在制备pd-1/pd-l1通路抑制剂中的应用 | |
CN109810153B (zh) | 芳香取代葡萄糖类化合物及其药物组合物的制备方法与镇痛应用 | |
CN103980198B (zh) | 生物碱Casuarinine H及其在制备治疗神经退行性疾病药物中的用途 | |
CN1107680C (zh) | 澳洲茄胺盐酸盐及其生产方法和在医药上的应用 | |
CN100546590C (zh) | 藤梨根抗肿瘤提取物及其制备方法和用途 | |
CN107213176B (zh) | 一种八仙花叶提取物及其药物组合物、制备方法和应用 | |
CN101390979B (zh) | 枳椇子提取物及其制备方法与在制备抗肿瘤药物中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 210047 room 1203, building D, 606 ningliu Road, Changlu street, Jiangbei new district, Nanjing City, Jiangsu Province Patentee after: Nanjing century Bokang Pharmaceutical Technology Co.,Ltd. Address before: 100070 Beijing science and Technology Park of Fengtai District Haiying Road No. 9 Jintang building 3 203 Patentee before: BEIJING CENTURY BIOCOM PHARMACEUTICAL TECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20201230 Address after: 226300 1-2 / F, C6 building, 266 Century Avenue, Nantong hi tech Zone, Nantong City, Jiangsu Province Patentee after: JIANGSU REPODX BIOTECHNOLOGY CO.,LTD. Address before: 210047 room 1203, building D, 606 ningliu Road, Changlu street, Jiangbei new district, Nanjing City, Jiangsu Province Patentee before: Nanjing century Bokang Pharmaceutical Technology Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110601 |